About BioLucent

Hologic, Inc. (NASDAQ: HOLX) has grown to become a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products created specifically to address the healthcare needs of women throughout the world. Their comprehensive suite of products spans nine key areas: mammography and breast biopsy; radiation treatment for early-stage breast cancer; cervical cancer screening; treatment for menorrhagia; permanent contraception; osteoporosis assessment; preterm birth risk assessment; mini C-arms for extremity imaging; as well as molecular diagnostic products, including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications. The core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. The complex health issues facing women today deserve and demand the singular dedication of a passionate company committed to doing everything in its power to help women live longer, stronger, healthier lives.

website icon
Website
employees icon
Employees
location icon
Headquarter
Bedford, Massachusetts
description icon
Founded
1985

BioLucent Alternatives

Industry
Financial Services
Industry
hospital & health care
Industry
Information Technology & Services
Industry
internet

Frequently Asked Questions about BioLucent

Who are the decision makers in BioLucent?

The decision makers in BioLucent are Vicki Clements, etc. Click to Find BioLucent decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more